USING DNA METHYLATION TO PREDICT WHITE BLOOD CELLS FREQUENCIES IN 

TUMOR TISSUE SAMPLES 

CS 229 â€“ FINAL PROJECT WRITE-UP â€“ FALL 2015 

 
 
 
 

Marcos M. Prunello 

Ying-Cheng Chris Lee 

Biomedical Informatics MS Student 

Electrical Engineering MS Student 

marcosp@stanford.edu 

leechris@stanford.edu 

Abstract 

Large  multi-cancer  data  sets  are  available  that  profile  the  epigenome  for  tumor  tissue  samples. 
However, such cancer samples are made up of a mixture of cell types and it is necessary to determine 
to which extent the samples are composed by tumor cells or by other cell types, such as blood cells. 
We built models that are able to estimate the frequency of different types of blood cells present 
in brain tumor tissue samples using only DNA methylation data registered on the samples, and 
marked the most important genes for this task. 

 
INTRODUCTION 

Cancer refers to a group of diseases characterized by an 
uncontrolled growth in cells which can extend to different 
parts  of  the  body,  generally  caused  by  changes  in  DNA. 
There  are  about  14.1  million  new  cases  per  year  in  the 
world and it causes about 14.6% of all human deaths. In 
the United States, the financial costs of cancer have been 
estimated  at  $1.16  trillion  dollars  per  year.  There  are 
many  different  types  of  cancers,  each  with  its  own 
subtypes.  

The  importance  of  epigenomics  when  studying  cancer 
cannot  be  understated.  Epigenomics  is  the  study  of 
epigenetic modifications, which include all the variations 
that  affect  gene  expression  without  altering  the  DNA 
sequence. Changes on top of DNA have shown to activate 
oncogenes  or  deactivate  tumor  suppressor  genes.  Large 
multi-cancer data sets are now available that profile the 
epigenome for tumor tissue samples. Nevertheless, such 
cancer  samples  are  made  up  of  a  mixture  of  cell  types. 
Mathematical  approaches  are  needed  to  deconvolve 
these  mixtures  and  determine  to  which  extent  the 
samples  are  composed  by  tumor  cells  or  by  other  cell 
types, such as blood cells. 

DNA  methylation,  an  epigenetic  process  consisting  of  a 
chemical  modification  of  DNA,  is  responsible  for  cellular 
differentiation  and  hence  can  be  used  to  distinguish 
distinct cell lineages.  

Our goal in this project was to predict the  proportion of 
different  blood  cell  types  in  tumor  tissue  samples  (our 
continuous  response)  using  DNA  methylation  data 
measured  for  an  extensive  set  of  genes  (our  predictors, 
also continuous), and to identify which are the genes (the 
features) that are most important for this prediction task. 
To  achieve  this,  we  tried  several  machine 
learning 
methods:  linear  regression  with  penalization,  K-nearest 

 

1 

neighbors, support vector regression and regression trees 
(basic  trees,  but  also  random  forests,  bagging  and 
boosting). 

 

RELATED WORK 

The  use  of  methylation  signatures  to  estimate  the 
distribution  of  blood  cell  types  in  a  sample  is  called 
deconvolution of DNA methylation and it involves learning 
the specific methylation signature of each cell type from a 
set  of  samples  of  purified  known  cell  subtypes 
representing gold-standard data, to later infer the type of 
cells present in the target samples. Some research in this 
topic  has  been  carried  out  lately,  but  it  stills  remains  a 
non-trivial problem with no clear solution. Houseman [1] 
described  a  method  which 
regression 
calibration,  where  a  methylation  signature  is  considered 
to  be  a  high  dimensional  multivariate  surrogate  for  the 
distribution  of  blood  cells.  Jaffe  [2]  tailored  Housemanâ€™s 
method  using  a  new  reference  set  produced  with  450k 
microarrays instead of 27k that was published by Reinius 
[3]. 

resembles 

In  a  first  stage  of  our  work  we  applied  Housemanâ€™s 
method in the same way as Jaffe. Since this method was 
developed  for  DNA  methylation  deconvolution  in  blood 
samples but we applied it in tissue samples, we looked for 
some  way  of  validation  of  these  results.  We  decided  to 
perform  gene  expression  deconvolution  on  the  same 
samples  with  a  well  established  and  validated  method, 
Cibersort  [4].  We  found  no  match  between  our  results 
from  the  deconvolution  of  DNA  methylation  and  those 
from  Cibersortâ€™s  gene  expression  deconvolution.  Facing 
these  negative  results,  we  decided  to  approach  the 
problem as described in the introduction, using the DNA 
methylation  data  to  predict  the  frequencies  of  the 
different  blood  cell  types,  using  as  ground  truth  the 

USING DNA METHYLATION TO PREDICT WHITE BLOOD CELLS FREQUENCIES IN 

TUMOR TISSUE SAMPLES 

CS 229 â€“ FINAL PROJECT WRITE-UP â€“ FALL 2015 

 
 
 
 

Marcos M. Prunello 

Ying-Cheng Chris Lee 

Biomedical Informatics MS Student 

Electrical Engineering MS Student 

marcosp@stanford.edu 

leechris@stanford.edu 

Abstract 

Large  multi-cancer  data  sets  are  available  that  profile  the  epigenome  for  tumor  tissue  samples. 
However, such cancer samples are made up of a mixture of cell types and it is necessary to determine 
to which extent the samples are composed by tumor cells or by other cell types, such as blood cells. 
We built models that are able to estimate the frequency of different types of blood cells present 
in brain tumor tissue samples using only DNA methylation data registered on the samples, and 
marked the most important genes for this task. 

 
INTRODUCTION 

Cancer refers to a group of diseases characterized by an 
uncontrolled growth in cells which can extend to different 
parts  of  the  body,  generally  caused  by  changes  in  DNA. 
There  are  about  14.1  million  new  cases  per  year  in  the 
world and it causes about 14.6% of all human deaths. In 
the United States, the financial costs of cancer have been 
estimated  at  $1.16  trillion  dollars  per  year.  There  are 
many  different  types  of  cancers,  each  with  its  own 
subtypes.  

The  importance  of  epigenomics  when  studying  cancer 
cannot  be  understated.  Epigenomics  is  the  study  of 
epigenetic modifications, which include all the variations 
that  affect  gene  expression  without  altering  the  DNA 
sequence. Changes on top of DNA have shown to activate 
oncogenes  or  deactivate  tumor  suppressor  genes.  Large 
multi-cancer data sets are now available that profile the 
epigenome for tumor tissue samples. Nevertheless, such 
cancer  samples  are  made  up  of  a  mixture  of  cell  types. 
Mathematical  approaches  are  needed  to  deconvolve 
these  mixtures  and  determine  to  which  extent  the 
samples  are  composed  by  tumor  cells  or  by  other  cell 
types, such as blood cells. 

DNA  methylation,  an  epigenetic  process  consisting  of  a 
chemical  modification  of  DNA,  is  responsible  for  cellular 
differentiation  and  hence  can  be  used  to  distinguish 
distinct cell lineages.  

Our goal in this project was to predict the  proportion of 
different  blood  cell  types  in  tumor  tissue  samples  (our 
continuous  response)  using  DNA  methylation  data 
measured  for  an  extensive  set  of  genes  (our  predictors, 
also continuous), and to identify which are the genes (the 
features) that are most important for this prediction task. 
To  achieve  this,  we  tried  several  machine 
learning 
methods:  linear  regression  with  penalization,  K-nearest 

 

1 

neighbors, support vector regression and regression trees 
(basic  trees,  but  also  random  forests,  bagging  and 
boosting). 

 

RELATED WORK 

The  use  of  methylation  signatures  to  estimate  the 
distribution  of  blood  cell  types  in  a  sample  is  called 
deconvolution of DNA methylation and it involves learning 
the specific methylation signature of each cell type from a 
set  of  samples  of  purified  known  cell  subtypes 
representing gold-standard data, to later infer the type of 
cells present in the target samples. Some research in this 
topic  has  been  carried  out  lately,  but  it  stills  remains  a 
non-trivial problem with no clear solution. Houseman [1] 
described  a  method  which 
regression 
calibration,  where  a  methylation  signature  is  considered 
to  be  a  high  dimensional  multivariate  surrogate  for  the 
distribution  of  blood  cells.  Jaffe  [2]  tailored  Housemanâ€™s 
method  using  a  new  reference  set  produced  with  450k 
microarrays instead of 27k that was published by Reinius 
[3]. 

resembles 

In  a  first  stage  of  our  work  we  applied  Housemanâ€™s 
method in the same way as Jaffe. Since this method was 
developed  for  DNA  methylation  deconvolution  in  blood 
samples but we applied it in tissue samples, we looked for 
some  way  of  validation  of  these  results.  We  decided  to 
perform  gene  expression  deconvolution  on  the  same 
samples  with  a  well  established  and  validated  method, 
Cibersort  [4].  We  found  no  match  between  our  results 
from  the  deconvolution  of  DNA  methylation  and  those 
from  Cibersortâ€™s  gene  expression  deconvolution.  Facing 
these  negative  results,  we  decided  to  approach  the 
problem as described in the introduction, using the DNA 
methylation  data  to  predict  the  frequencies  of  the 
different  blood  cell  types,  using  as  ground  truth  the 

frequencies  provided  by  Cibersort  through 
expression deconvolution. 

its  gene 

 

DATA SET AND FEATURES 

Gliobastoma cancer data 

We decided to focus our analysis in Glioblastoma (GBM), 
which is the most common and most aggressive malignant 
primary brain tumor. We extracted methylation  data for 
GBM  cancer  samples  from  The  Cancer  Genome  Atlas 
(TCGA).  Illumina  Infinium  HumanMethylation  27k  were 
used to produce TCGAâ€™s DNA methylation  data, which is 
quantified  with  beta  values  in  a  range  from  0  to  1 
representing the proportion of methylation signal  versus 
total signal. Values close to 1 represent high levels of DNA 
methylation and values  close to 0 low levels. Those CpG 
sites  with  more  than  10%  missing  values  in  all  samples 
were  removed  and  15-K  Nearest  Neighbor 
(KNN) 
algorithm  was  applied  to  estimate  the  rest  of  missing 
values [5]. TCGA samples were analyzed in batches so we 
used  Combat  to  adjust  for  this  effect  [6].  We  also 
extracted matched gene expression  data, produced with 
microarrays  technology.  Data  was 
log-transformed, 
infinities were replaced with a low value and missing value 
estimation  and  batch  correction  were  applied  as 
described  before.  The  final  data  set  consisted  of  321 
samples. 

Response features 

In  our  prediction  task, the  response  is  the  proportion  of 
seven  different  blood  cell  types  in  the  tumor  tissue 
samples: D4+ T cells, CD8+ T cells, CD56+ NK cells, CD19+ 
B  cells,  CD14+  monocytes,  neutrophils,  and  eosinophils. 
We generated our response features using Cibersort  [4], 
an  algorithm  for  gene  expression  deconvolution  which 
accurately  quantifies  the  relative  levels  of  distinct  cell 
types within a complex gene expression admixture. Such 
mixtures  can  derive  from  malignant  or  normal  solid 
tissues. 

Predictors 

Our predictors are the  methylation measurements (beta 
values)  on  a  total  of  17812  genes  for  each  of  the  321 
samples.  With  this  data  set,  we  faced  two  challenges. 
First, methylation data is known to be noisy, and second, 
we  needed  to  reduce  the  number  of  available  features 
(genes) though doing some sort of variable selection. We 
decided to approach these two issues analyzing the set of 
predictors with an algorithm called MethylMix [7], which 
identifies  hypo-  and  hyper-methylated  genes  in  cancer 
samples that are also predictive of transcription through 
the following three steps (Figure 1). 

First, for each gene a beta mixture model is fitted to the 
methylation  beta  values  to  generate  subgroups  of 

 

the 

samples  with  similar  DNA  methylation  levels,  using  an 
Expectation Maximization algorithm for mixtures of beta 
distributions (since beta-values represent the proportion 
of  methylation).  Starting  with  a  model  with  only  one 
component,  a  new  beta  mixture  component  is  added 
iteratively if it improves the fit of the model according to 
Information  Criterion  (BIC)  for  model 
the  Bayesian 
selection.  Each  of 
final  mixture  components 
represents  a  subset  of  patients  with  a  common 
methylation profile (a â€œmethylation stateâ€).  Secondly, for 
each of these subgroups the difference between its mean 
methylation  and  the  mean  methylation  in  normal  tissue 
samples 
it 
is  called  DM-value 
(Differential  Methylation).  Only 
those  genes  with 
significant  DM-values  are  selected  for  the  third  step,  in 
which a linear regression is used to model the expression 
of  each  gene  by  its  own  methylation.  If  there  is  a 
significant negative association between methylation and 
gene  expression,  the  gene 
is  finally  reported  as  a 
methylation-driven genes. 

is  calculated  and 

Figure  1.  Representation  of  MethylMix  algorithm.  This  is  a 
methylation-driven  gene  because  it  shows  methylation  states 
that  differ  from  variation  in  normal  samples  and  also  its 
methylation  profile  has  an  effect  in  gene  expression.  Each 
sample  receives  a  DM  value,  which  is  the  difference  between 
mean methylation in its group and mean methylation in normal 
samples. 

l

 
)
s
e
p
m
a
s
 
#
(
 

y
c
n
e
u
q
e
r
F

MET in normal samples 

DM VALUE 

0 

Beta-value (methylation) 

1 

 

n
o
i
s
s
e
r
p
x
E
e
n
e
G

 

            

 

Beta-value (methylation) 

 

Applying this algorithm to the GBM data, from the original 
set of 17812 genes we identified 455 methylation-driven 
genes  which  constituted  our  reduced  set  of  predictors. 

2 

USING DNA METHYLATION TO PREDICT WHITE BLOOD CELLS FREQUENCIES IN 

TUMOR TISSUE SAMPLES 

CS 229 â€“ FINAL PROJECT WRITE-UP â€“ FALL 2015 

 
 
 
 

Marcos M. Prunello 

Ying-Cheng Chris Lee 

Biomedical Informatics MS Student 

Electrical Engineering MS Student 

marcosp@stanford.edu 

leechris@stanford.edu 

Abstract 

Large  multi-cancer  data  sets  are  available  that  profile  the  epigenome  for  tumor  tissue  samples. 
However, such cancer samples are made up of a mixture of cell types and it is necessary to determine 
to which extent the samples are composed by tumor cells or by other cell types, such as blood cells. 
We built models that are able to estimate the frequency of different types of blood cells present 
in brain tumor tissue samples using only DNA methylation data registered on the samples, and 
marked the most important genes for this task. 

 
INTRODUCTION 

Cancer refers to a group of diseases characterized by an 
uncontrolled growth in cells which can extend to different 
parts  of  the  body,  generally  caused  by  changes  in  DNA. 
There  are  about  14.1  million  new  cases  per  year  in  the 
world and it causes about 14.6% of all human deaths. In 
the United States, the financial costs of cancer have been 
estimated  at  $1.16  trillion  dollars  per  year.  There  are 
many  different  types  of  cancers,  each  with  its  own 
subtypes.  

The  importance  of  epigenomics  when  studying  cancer 
cannot  be  understated.  Epigenomics  is  the  study  of 
epigenetic modifications, which include all the variations 
that  affect  gene  expression  without  altering  the  DNA 
sequence. Changes on top of DNA have shown to activate 
oncogenes  or  deactivate  tumor  suppressor  genes.  Large 
multi-cancer data sets are now available that profile the 
epigenome for tumor tissue samples. Nevertheless, such 
cancer  samples  are  made  up  of  a  mixture  of  cell  types. 
Mathematical  approaches  are  needed  to  deconvolve 
these  mixtures  and  determine  to  which  extent  the 
samples  are  composed  by  tumor  cells  or  by  other  cell 
types, such as blood cells. 

DNA  methylation,  an  epigenetic  process  consisting  of  a 
chemical  modification  of  DNA,  is  responsible  for  cellular 
differentiation  and  hence  can  be  used  to  distinguish 
distinct cell lineages.  

Our goal in this project was to predict the  proportion of 
different  blood  cell  types  in  tumor  tissue  samples  (our 
continuous  response)  using  DNA  methylation  data 
measured  for  an  extensive  set  of  genes  (our  predictors, 
also continuous), and to identify which are the genes (the 
features) that are most important for this prediction task. 
To  achieve  this,  we  tried  several  machine 
learning 
methods:  linear  regression  with  penalization,  K-nearest 

 

1 

neighbors, support vector regression and regression trees 
(basic  trees,  but  also  random  forests,  bagging  and 
boosting). 

 

RELATED WORK 

The  use  of  methylation  signatures  to  estimate  the 
distribution  of  blood  cell  types  in  a  sample  is  called 
deconvolution of DNA methylation and it involves learning 
the specific methylation signature of each cell type from a 
set  of  samples  of  purified  known  cell  subtypes 
representing gold-standard data, to later infer the type of 
cells present in the target samples. Some research in this 
topic  has  been  carried  out  lately,  but  it  stills  remains  a 
non-trivial problem with no clear solution. Houseman [1] 
described  a  method  which 
regression 
calibration,  where  a  methylation  signature  is  considered 
to  be  a  high  dimensional  multivariate  surrogate  for  the 
distribution  of  blood  cells.  Jaffe  [2]  tailored  Housemanâ€™s 
method  using  a  new  reference  set  produced  with  450k 
microarrays instead of 27k that was published by Reinius 
[3]. 

resembles 

In  a  first  stage  of  our  work  we  applied  Housemanâ€™s 
method in the same way as Jaffe. Since this method was 
developed  for  DNA  methylation  deconvolution  in  blood 
samples but we applied it in tissue samples, we looked for 
some  way  of  validation  of  these  results.  We  decided  to 
perform  gene  expression  deconvolution  on  the  same 
samples  with  a  well  established  and  validated  method, 
Cibersort  [4].  We  found  no  match  between  our  results 
from  the  deconvolution  of  DNA  methylation  and  those 
from  Cibersortâ€™s  gene  expression  deconvolution.  Facing 
these  negative  results,  we  decided  to  approach  the 
problem as described in the introduction, using the DNA 
methylation  data  to  predict  the  frequencies  of  the 
different  blood  cell  types,  using  as  ground  truth  the 

frequencies  provided  by  Cibersort  through 
expression deconvolution. 

its  gene 

 

DATA SET AND FEATURES 

Gliobastoma cancer data 

We decided to focus our analysis in Glioblastoma (GBM), 
which is the most common and most aggressive malignant 
primary brain tumor. We extracted methylation  data for 
GBM  cancer  samples  from  The  Cancer  Genome  Atlas 
(TCGA).  Illumina  Infinium  HumanMethylation  27k  were 
used to produce TCGAâ€™s DNA methylation  data, which is 
quantified  with  beta  values  in  a  range  from  0  to  1 
representing the proportion of methylation signal  versus 
total signal. Values close to 1 represent high levels of DNA 
methylation and values  close to 0 low levels. Those CpG 
sites  with  more  than  10%  missing  values  in  all  samples 
were  removed  and  15-K  Nearest  Neighbor 
(KNN) 
algorithm  was  applied  to  estimate  the  rest  of  missing 
values [5]. TCGA samples were analyzed in batches so we 
used  Combat  to  adjust  for  this  effect  [6].  We  also 
extracted matched gene expression  data, produced with 
microarrays  technology.  Data  was 
log-transformed, 
infinities were replaced with a low value and missing value 
estimation  and  batch  correction  were  applied  as 
described  before.  The  final  data  set  consisted  of  321 
samples. 

Response features 

In  our  prediction  task, the  response  is  the  proportion  of 
seven  different  blood  cell  types  in  the  tumor  tissue 
samples: D4+ T cells, CD8+ T cells, CD56+ NK cells, CD19+ 
B  cells,  CD14+  monocytes,  neutrophils,  and  eosinophils. 
We generated our response features using Cibersort  [4], 
an  algorithm  for  gene  expression  deconvolution  which 
accurately  quantifies  the  relative  levels  of  distinct  cell 
types within a complex gene expression admixture. Such 
mixtures  can  derive  from  malignant  or  normal  solid 
tissues. 

Predictors 

Our predictors are the  methylation measurements (beta 
values)  on  a  total  of  17812  genes  for  each  of  the  321 
samples.  With  this  data  set,  we  faced  two  challenges. 
First, methylation data is known to be noisy, and second, 
we  needed  to  reduce  the  number  of  available  features 
(genes) though doing some sort of variable selection. We 
decided to approach these two issues analyzing the set of 
predictors with an algorithm called MethylMix [7], which 
identifies  hypo-  and  hyper-methylated  genes  in  cancer 
samples that are also predictive of transcription through 
the following three steps (Figure 1). 

First, for each gene a beta mixture model is fitted to the 
methylation  beta  values  to  generate  subgroups  of 

 

the 

samples  with  similar  DNA  methylation  levels,  using  an 
Expectation Maximization algorithm for mixtures of beta 
distributions (since beta-values represent the proportion 
of  methylation).  Starting  with  a  model  with  only  one 
component,  a  new  beta  mixture  component  is  added 
iteratively if it improves the fit of the model according to 
Information  Criterion  (BIC)  for  model 
the  Bayesian 
selection.  Each  of 
final  mixture  components 
represents  a  subset  of  patients  with  a  common 
methylation profile (a â€œmethylation stateâ€).  Secondly, for 
each of these subgroups the difference between its mean 
methylation  and  the  mean  methylation  in  normal  tissue 
samples 
it 
is  called  DM-value 
(Differential  Methylation).  Only 
those  genes  with 
significant  DM-values  are  selected  for  the  third  step,  in 
which a linear regression is used to model the expression 
of  each  gene  by  its  own  methylation.  If  there  is  a 
significant negative association between methylation and 
gene  expression,  the  gene 
is  finally  reported  as  a 
methylation-driven genes. 

is  calculated  and 

Figure  1.  Representation  of  MethylMix  algorithm.  This  is  a 
methylation-driven  gene  because  it  shows  methylation  states 
that  differ  from  variation  in  normal  samples  and  also  its 
methylation  profile  has  an  effect  in  gene  expression.  Each 
sample  receives  a  DM  value,  which  is  the  difference  between 
mean methylation in its group and mean methylation in normal 
samples. 

l

 
)
s
e
p
m
a
s
 
#
(
 

y
c
n
e
u
q
e
r
F

MET in normal samples 

DM VALUE 

0 

Beta-value (methylation) 

1 

 

n
o
i
s
s
e
r
p
x
E
e
n
e
G

 

            

 

Beta-value (methylation) 

 

Applying this algorithm to the GBM data, from the original 
set of 17812 genes we identified 455 methylation-driven 
genes  which  constituted  our  reduced  set  of  predictors. 

2 

Furthermore,  each  sample  for  each  gene  can  be 
represented  by  the  DM-value  of  the  group  to  which 
belongs, in addition to its original raw methylation value 
(beta  value).  DM-values  were  shown  to  perform  better 
than  raw  methylation  in  some  scenarios,  provided  that 
they constitute a less noisy version of the data [8]. In this 
way,  we  had  two  matrices  of  predictors,  one  with  the 
original methylation values and other with the DM-values, 
for  each  of  the  455  MethylMix  genes  (Figure  2).  We 
trained our predictive models in both. 

Figure 2. Heatmaps of the 321 samples and 455 genes for both 
raw data and DM-values 

Raw beta values 

Genes 

DM-values 

l

 
s
e
p
m
a
S

l

 
s
e
p
m
a
S

evaluated  the  performance  with  Mean  Squared  Error 
(MSE).  All  the  analysis  were  performed  in  R  [9].  In  the 
following paragraphs we described the methods that we 
used. In  

K-Nearest Neighbors Regression (KNNR) 

Given a value for K and a prediction point, KNNR identifies 
the  K training  observations  that  are  closest  to  the given 
point  and  predicts  its  response  with  the  average  of  the 
response  of  the  K  closest  data  points.  This  is  a  non-
parametric method. The optimal number K was selected 
with 10 fold CV. This method was implemented with the R 
package â€œcaretâ€ [10]. 

Linear regression with L1 norm penalization 

This method, also known as LASSO, fits a penalized linear 
regression  model,  where  the  coefficients  are  penalized 
using  L1  norm.  This  forces  some  of  the  coefficient 
estimates to be zero when the tuning parameter ğœ† is large 
enough. Hence, this model is in itself a variable selection 
method, yielding a sparse model, very convenient in our 
application provided that we have 455 predictors and 321 
samples. The objective function being minimized is: 

ğ‘›

ğ‘š
âˆ‘ (ğ‘¦ğ‘– âˆ’ ğ›½0 âˆ’ âˆ‘ ğ›½ğ‘—ğ‘¥ğ‘–ğ‘—
ğ‘–=1

ğ‘—=1

2

ğ‘›

 )

+ ğœ† âˆ‘ |ğ›½ğ‘—|
 

ğ‘—=1

(1) 

We selected the penalization parameter ğœ† with 10 fold CV. 
This  method  was  implemented  using  the  R  package 
â€œglmnetâ€ [11]. 

Support Vector Regression (SVR) 

SVR is an extension of Support Vector Machines (SVM) for 
cases where the response is continuous instead of binary. 
SVR contains all the main features that characterize SVM, 
with a loss function that ignores errors situated within a 
certain distance of the true value. This type of function is 
often called epsilon intensive loss function, since a margin 
of tolerance ğœ– is set. The dual representation of the model 
is given by: 

Genes 

1
2

min

ğ›¼

 

(ğ›¼ âˆ’ ğ›¼ âˆ—)ğ‘‡ğ‘„(ğ›¼ âˆ’ ğ›¼ âˆ—) + ğœ– âˆ‘(ğ›¼ğ‘– + ğ›¼ğ‘–

âˆ— )

+ âˆ‘ ğ‘¦ğ‘–(ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

âˆ— )

 

ğ‘š

ğ‘š

ğ‘–=1

ğ‘–=1

(2) 

 

METHODS 

We  divided  our  321  samples  into  one  training  set  (80%) 
and  one  test  set  (20%).  We  trained  several  machine 
learning methods to predict the frequencies of each of the 
7  blood  cell  subtypes  individually,  using  both  the  raw 
methylation  and  the  DM-values  training  sets.  We  tuned 
the  parameters  required  for  each  method  with  10-fold 
cross  validation  (CV),  and  once  selected  the  optimal 
parameters, we refitted the model in the whole training 
set. Finally, we predicted the response in the test set, and 

 

such that: 0 â‰¤   ğ›¼ğ‘–, ğ›¼ğ‘–

âˆ— â‰¤ ğ¶, ğ‘– = 1, â€¦ , ğ‘š, âˆ‘ (ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

ğ‘™
ğ‘–=1

âˆ— )

= 0 

positive 

where ğ¶ is the upper bound for the cost parameter, ğ‘„ is 
an  ğ‘šğ‘¥ğ‘š 
semidefinite  matrix,  ğ‘„ğ‘–ğ‘— =
ğ‘¦ğ‘–ğ‘¦ğ‘—ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—), ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—) = ğœ™(ğ‘¥ğ‘–)ğ‘‡ğœ™(ğ‘¥ğ‘—) is a kernel and ğ‘š 
is the number of observations. We implemented SVR with 
radial or polynomial kernel, but also with no kernel at all 
(Table  1).  In  each  case,  the  required  parameters  were 
selected with 10 fold CV. SVR was implemented with the 
R package â€œe1071â€ [12]. 

 

3 

USING DNA METHYLATION TO PREDICT WHITE BLOOD CELLS FREQUENCIES IN 

TUMOR TISSUE SAMPLES 

CS 229 â€“ FINAL PROJECT WRITE-UP â€“ FALL 2015 

 
 
 
 

Marcos M. Prunello 

Ying-Cheng Chris Lee 

Biomedical Informatics MS Student 

Electrical Engineering MS Student 

marcosp@stanford.edu 

leechris@stanford.edu 

Abstract 

Large  multi-cancer  data  sets  are  available  that  profile  the  epigenome  for  tumor  tissue  samples. 
However, such cancer samples are made up of a mixture of cell types and it is necessary to determine 
to which extent the samples are composed by tumor cells or by other cell types, such as blood cells. 
We built models that are able to estimate the frequency of different types of blood cells present 
in brain tumor tissue samples using only DNA methylation data registered on the samples, and 
marked the most important genes for this task. 

 
INTRODUCTION 

Cancer refers to a group of diseases characterized by an 
uncontrolled growth in cells which can extend to different 
parts  of  the  body,  generally  caused  by  changes  in  DNA. 
There  are  about  14.1  million  new  cases  per  year  in  the 
world and it causes about 14.6% of all human deaths. In 
the United States, the financial costs of cancer have been 
estimated  at  $1.16  trillion  dollars  per  year.  There  are 
many  different  types  of  cancers,  each  with  its  own 
subtypes.  

The  importance  of  epigenomics  when  studying  cancer 
cannot  be  understated.  Epigenomics  is  the  study  of 
epigenetic modifications, which include all the variations 
that  affect  gene  expression  without  altering  the  DNA 
sequence. Changes on top of DNA have shown to activate 
oncogenes  or  deactivate  tumor  suppressor  genes.  Large 
multi-cancer data sets are now available that profile the 
epigenome for tumor tissue samples. Nevertheless, such 
cancer  samples  are  made  up  of  a  mixture  of  cell  types. 
Mathematical  approaches  are  needed  to  deconvolve 
these  mixtures  and  determine  to  which  extent  the 
samples  are  composed  by  tumor  cells  or  by  other  cell 
types, such as blood cells. 

DNA  methylation,  an  epigenetic  process  consisting  of  a 
chemical  modification  of  DNA,  is  responsible  for  cellular 
differentiation  and  hence  can  be  used  to  distinguish 
distinct cell lineages.  

Our goal in this project was to predict the  proportion of 
different  blood  cell  types  in  tumor  tissue  samples  (our 
continuous  response)  using  DNA  methylation  data 
measured  for  an  extensive  set  of  genes  (our  predictors, 
also continuous), and to identify which are the genes (the 
features) that are most important for this prediction task. 
To  achieve  this,  we  tried  several  machine 
learning 
methods:  linear  regression  with  penalization,  K-nearest 

 

1 

neighbors, support vector regression and regression trees 
(basic  trees,  but  also  random  forests,  bagging  and 
boosting). 

 

RELATED WORK 

The  use  of  methylation  signatures  to  estimate  the 
distribution  of  blood  cell  types  in  a  sample  is  called 
deconvolution of DNA methylation and it involves learning 
the specific methylation signature of each cell type from a 
set  of  samples  of  purified  known  cell  subtypes 
representing gold-standard data, to later infer the type of 
cells present in the target samples. Some research in this 
topic  has  been  carried  out  lately,  but  it  stills  remains  a 
non-trivial problem with no clear solution. Houseman [1] 
described  a  method  which 
regression 
calibration,  where  a  methylation  signature  is  considered 
to  be  a  high  dimensional  multivariate  surrogate  for  the 
distribution  of  blood  cells.  Jaffe  [2]  tailored  Housemanâ€™s 
method  using  a  new  reference  set  produced  with  450k 
microarrays instead of 27k that was published by Reinius 
[3]. 

resembles 

In  a  first  stage  of  our  work  we  applied  Housemanâ€™s 
method in the same way as Jaffe. Since this method was 
developed  for  DNA  methylation  deconvolution  in  blood 
samples but we applied it in tissue samples, we looked for 
some  way  of  validation  of  these  results.  We  decided  to 
perform  gene  expression  deconvolution  on  the  same 
samples  with  a  well  established  and  validated  method, 
Cibersort  [4].  We  found  no  match  between  our  results 
from  the  deconvolution  of  DNA  methylation  and  those 
from  Cibersortâ€™s  gene  expression  deconvolution.  Facing 
these  negative  results,  we  decided  to  approach  the 
problem as described in the introduction, using the DNA 
methylation  data  to  predict  the  frequencies  of  the 
different  blood  cell  types,  using  as  ground  truth  the 

frequencies  provided  by  Cibersort  through 
expression deconvolution. 

its  gene 

 

DATA SET AND FEATURES 

Gliobastoma cancer data 

We decided to focus our analysis in Glioblastoma (GBM), 
which is the most common and most aggressive malignant 
primary brain tumor. We extracted methylation  data for 
GBM  cancer  samples  from  The  Cancer  Genome  Atlas 
(TCGA).  Illumina  Infinium  HumanMethylation  27k  were 
used to produce TCGAâ€™s DNA methylation  data, which is 
quantified  with  beta  values  in  a  range  from  0  to  1 
representing the proportion of methylation signal  versus 
total signal. Values close to 1 represent high levels of DNA 
methylation and values  close to 0 low levels. Those CpG 
sites  with  more  than  10%  missing  values  in  all  samples 
were  removed  and  15-K  Nearest  Neighbor 
(KNN) 
algorithm  was  applied  to  estimate  the  rest  of  missing 
values [5]. TCGA samples were analyzed in batches so we 
used  Combat  to  adjust  for  this  effect  [6].  We  also 
extracted matched gene expression  data, produced with 
microarrays  technology.  Data  was 
log-transformed, 
infinities were replaced with a low value and missing value 
estimation  and  batch  correction  were  applied  as 
described  before.  The  final  data  set  consisted  of  321 
samples. 

Response features 

In  our  prediction  task, the  response  is  the  proportion  of 
seven  different  blood  cell  types  in  the  tumor  tissue 
samples: D4+ T cells, CD8+ T cells, CD56+ NK cells, CD19+ 
B  cells,  CD14+  monocytes,  neutrophils,  and  eosinophils. 
We generated our response features using Cibersort  [4], 
an  algorithm  for  gene  expression  deconvolution  which 
accurately  quantifies  the  relative  levels  of  distinct  cell 
types within a complex gene expression admixture. Such 
mixtures  can  derive  from  malignant  or  normal  solid 
tissues. 

Predictors 

Our predictors are the  methylation measurements (beta 
values)  on  a  total  of  17812  genes  for  each  of  the  321 
samples.  With  this  data  set,  we  faced  two  challenges. 
First, methylation data is known to be noisy, and second, 
we  needed  to  reduce  the  number  of  available  features 
(genes) though doing some sort of variable selection. We 
decided to approach these two issues analyzing the set of 
predictors with an algorithm called MethylMix [7], which 
identifies  hypo-  and  hyper-methylated  genes  in  cancer 
samples that are also predictive of transcription through 
the following three steps (Figure 1). 

First, for each gene a beta mixture model is fitted to the 
methylation  beta  values  to  generate  subgroups  of 

 

the 

samples  with  similar  DNA  methylation  levels,  using  an 
Expectation Maximization algorithm for mixtures of beta 
distributions (since beta-values represent the proportion 
of  methylation).  Starting  with  a  model  with  only  one 
component,  a  new  beta  mixture  component  is  added 
iteratively if it improves the fit of the model according to 
Information  Criterion  (BIC)  for  model 
the  Bayesian 
selection.  Each  of 
final  mixture  components 
represents  a  subset  of  patients  with  a  common 
methylation profile (a â€œmethylation stateâ€).  Secondly, for 
each of these subgroups the difference between its mean 
methylation  and  the  mean  methylation  in  normal  tissue 
samples 
it 
is  called  DM-value 
(Differential  Methylation).  Only 
those  genes  with 
significant  DM-values  are  selected  for  the  third  step,  in 
which a linear regression is used to model the expression 
of  each  gene  by  its  own  methylation.  If  there  is  a 
significant negative association between methylation and 
gene  expression,  the  gene 
is  finally  reported  as  a 
methylation-driven genes. 

is  calculated  and 

Figure  1.  Representation  of  MethylMix  algorithm.  This  is  a 
methylation-driven  gene  because  it  shows  methylation  states 
that  differ  from  variation  in  normal  samples  and  also  its 
methylation  profile  has  an  effect  in  gene  expression.  Each 
sample  receives  a  DM  value,  which  is  the  difference  between 
mean methylation in its group and mean methylation in normal 
samples. 

l

 
)
s
e
p
m
a
s
 
#
(
 

y
c
n
e
u
q
e
r
F

MET in normal samples 

DM VALUE 

0 

Beta-value (methylation) 

1 

 

n
o
i
s
s
e
r
p
x
E
e
n
e
G

 

            

 

Beta-value (methylation) 

 

Applying this algorithm to the GBM data, from the original 
set of 17812 genes we identified 455 methylation-driven 
genes  which  constituted  our  reduced  set  of  predictors. 

2 

Furthermore,  each  sample  for  each  gene  can  be 
represented  by  the  DM-value  of  the  group  to  which 
belongs, in addition to its original raw methylation value 
(beta  value).  DM-values  were  shown  to  perform  better 
than  raw  methylation  in  some  scenarios,  provided  that 
they constitute a less noisy version of the data [8]. In this 
way,  we  had  two  matrices  of  predictors,  one  with  the 
original methylation values and other with the DM-values, 
for  each  of  the  455  MethylMix  genes  (Figure  2).  We 
trained our predictive models in both. 

Figure 2. Heatmaps of the 321 samples and 455 genes for both 
raw data and DM-values 

Raw beta values 

Genes 

DM-values 

l

 
s
e
p
m
a
S

l

 
s
e
p
m
a
S

evaluated  the  performance  with  Mean  Squared  Error 
(MSE).  All  the  analysis  were  performed  in  R  [9].  In  the 
following paragraphs we described the methods that we 
used. In  

K-Nearest Neighbors Regression (KNNR) 

Given a value for K and a prediction point, KNNR identifies 
the  K training  observations  that  are  closest  to  the given 
point  and  predicts  its  response  with  the  average  of  the 
response  of  the  K  closest  data  points.  This  is  a  non-
parametric method. The optimal number K was selected 
with 10 fold CV. This method was implemented with the R 
package â€œcaretâ€ [10]. 

Linear regression with L1 norm penalization 

This method, also known as LASSO, fits a penalized linear 
regression  model,  where  the  coefficients  are  penalized 
using  L1  norm.  This  forces  some  of  the  coefficient 
estimates to be zero when the tuning parameter ğœ† is large 
enough. Hence, this model is in itself a variable selection 
method, yielding a sparse model, very convenient in our 
application provided that we have 455 predictors and 321 
samples. The objective function being minimized is: 

ğ‘›

ğ‘š
âˆ‘ (ğ‘¦ğ‘– âˆ’ ğ›½0 âˆ’ âˆ‘ ğ›½ğ‘—ğ‘¥ğ‘–ğ‘—
ğ‘–=1

ğ‘—=1

2

ğ‘›

 )

+ ğœ† âˆ‘ |ğ›½ğ‘—|
 

ğ‘—=1

(1) 

We selected the penalization parameter ğœ† with 10 fold CV. 
This  method  was  implemented  using  the  R  package 
â€œglmnetâ€ [11]. 

Support Vector Regression (SVR) 

SVR is an extension of Support Vector Machines (SVM) for 
cases where the response is continuous instead of binary. 
SVR contains all the main features that characterize SVM, 
with a loss function that ignores errors situated within a 
certain distance of the true value. This type of function is 
often called epsilon intensive loss function, since a margin 
of tolerance ğœ– is set. The dual representation of the model 
is given by: 

Genes 

1
2

min

ğ›¼

 

(ğ›¼ âˆ’ ğ›¼ âˆ—)ğ‘‡ğ‘„(ğ›¼ âˆ’ ğ›¼ âˆ—) + ğœ– âˆ‘(ğ›¼ğ‘– + ğ›¼ğ‘–

âˆ— )

+ âˆ‘ ğ‘¦ğ‘–(ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

âˆ— )

 

ğ‘š

ğ‘š

ğ‘–=1

ğ‘–=1

(2) 

 

METHODS 

We  divided  our  321  samples  into  one  training  set  (80%) 
and  one  test  set  (20%).  We  trained  several  machine 
learning methods to predict the frequencies of each of the 
7  blood  cell  subtypes  individually,  using  both  the  raw 
methylation  and  the  DM-values  training  sets.  We  tuned 
the  parameters  required  for  each  method  with  10-fold 
cross  validation  (CV),  and  once  selected  the  optimal 
parameters, we refitted the model in the whole training 
set. Finally, we predicted the response in the test set, and 

 

such that: 0 â‰¤   ğ›¼ğ‘–, ğ›¼ğ‘–

âˆ— â‰¤ ğ¶, ğ‘– = 1, â€¦ , ğ‘š, âˆ‘ (ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

ğ‘™
ğ‘–=1

âˆ— )

= 0 

positive 

where ğ¶ is the upper bound for the cost parameter, ğ‘„ is 
an  ğ‘šğ‘¥ğ‘š 
semidefinite  matrix,  ğ‘„ğ‘–ğ‘— =
ğ‘¦ğ‘–ğ‘¦ğ‘—ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—), ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—) = ğœ™(ğ‘¥ğ‘–)ğ‘‡ğœ™(ğ‘¥ğ‘—) is a kernel and ğ‘š 
is the number of observations. We implemented SVR with 
radial or polynomial kernel, but also with no kernel at all 
(Table  1).  In  each  case,  the  required  parameters  were 
selected with 10 fold CV. SVR was implemented with the 
R package â€œe1071â€ [12]. 

 

3 

Table 1. Kernels applied in SVR 

Kernel 

Formula 

Linear 
Radial 

ğ‘¢ğ‘‡ğ‘£ 

2
exp (âˆ’ğ›¾||ğ‘¢ âˆ’ ğ‘£||

 ) 

Polynomial 

ğ›¾(ğ‘¢ğ‘‡ğ‘£)ğ‘‘ 

Parameters 

tuned with CV 

ğ¶, ğœ– 
ğ¶, ğœ–, ğ›¾ 

ğ¶, ğœ–, ğ›¾, ğ‘‘ 

 

Tree-based methods 

to 

improve 

these  approaches 

forests,  and  boosting 

Tree-based  methods  for  regression  involve  segmenting 
the predictor space into a number of simple regions and 
using the mean of the training observations in the region 
to which a point that we want to predict belongs. We first 
fitted a basic regression tree and pruned it with 10 fold CV. 
Since  basic  regression  trees  do  not  always  provide  the 
best results in terms of accuracy, we also applied bagging, 
random 
the 
performance.  Each  of 
involves 
producing multiple trees which are then combined to yield 
a single prediction. Bagging takes B bootstrap samples of 
the  training  observations,  fits  several  regression  trees 
then averages the predicted values, helping to reduce the 
characteristic  high  variance  in  a  basic  regression  tree. 
Random trees contributes to decorrelate the trees built by 
bagging, by taking a random sample of some predictors as 
split candidates each time a split in a tree is considered. 
Boosting  is  another  which  in  the  context  of  regression 
trees involves growing the trees sequentially, each tree is 
grown using information from previously grown trees. The 
number  of  trees  as  well  as  other  parameters  like  the 
number of predictors chosen randomly in random forests 
were  optimized 
looking  at  out-of-bag  (OOB)  error 
estimates.  We  used  the  R  packages  â€œtreeâ€  [13], 
â€œrandomForestsâ€ [14] and â€œgbmâ€ [15]. 

 

RESULTS 

A  total  of  126  models  were  trained,  given  our  7  cell 
subtypes,  2  data  types,  and  9  candidate  models  (KNNR, 
Lasso,  SVR  with  3  different  kernels  and  4  tree-based 
methods).  After  optimizing  the  parameters  for  each 
model with 10 fold CV, the model was re fit in the whole 
training  set  and  predictions  were  obtained  for  both  the 
training and the independent test set.  Then we calculated 
different measurements  to  evaluate  the  performance  of 
the model but we used the traditional Mean Square Error 
(MSE) on the test set to select the best performing model 
for each subtype (Table 2). 

Looking not only at the best performing model but also to 
the top models for each cell subtype, we did not find that 
either  the  raw  methylation  data  or  the  DM-values 
outperformed the other data type in most cases. Although 
we  hypothesized  that  the  DM-values  could  performed 
better as they represent a de-noised version of the data, 

 

it seems that the raw methylation data was enough for the 
prediction task. 

Table 2. Top performing model for each cell subtype 

Subtype 

B cells 
CD4 
CD8 
Eos 
Mon 
Neu 
NK 

Best Model 

Obs 
Mean 
0.0941  Raw - SVR Lin 
0.0045  Raw - Lasso 
0.1733  DM -Rand Forests 
0.1404  Raw - Boosting 
0.2449  DM - SVR Linear 
0.0547  Raw - SVR Radial 
0.2882  Raw - SVR Polyn 

MSE 
Test 
0.0043 
0.0007 
0.0181 
0.0045 
0.0095 
0.0143 
0.0053 

MSE 
Train 
0.002 
0.0003 
0.0032 
0.0039 
0.0089 
0.0076 
0.0038 

Cor 
Test 
0.545 
0.3907 
0.3948 
0.1286 
0.2716 
0.4331 
0.6236 

Cor 
Train 
0.7915 
0.8812 
0.9877 
0.559 
0.6221 
0.8581 
0.7769 

They 

the  best. 

In terms of the models, different methods worked better 
for different cell subtypes, but in 4 out of the 7 subtypes 
it was support vector regression the one that achieved the 
best results. For B cells and Monocytes, the best model did 
not  require  any  kernel,  whereas  for  Neutrophils  and 
Natural  Killers  used  a  radial  or  a  polynomial  kernel, 
respectively. For CD8 and Eosinophils, random forests and 
boosting  performed 
represent 
improvements over the basic regression tree, since both 
fit several trees. Random forests takes random samples of 
the  predictors  to  make  a  final  prediction  using  not  very 
correlated  trees,  and  boosting in  each  new  tree weights 
more those points with bigger errors in the previous trees, 
so  it  is  reasonable  to  see  that  these  methods  worked 
better  than  the  basic  regression  tree.  For  CD4,  the  best 
performing model is LASSO. Nevertheless, results for CD4 
should  be  interpreted  with  care,  since  the  frequency  of 
CD4  in  the  samples is  very  low  and the response  vector 
consists  mainly  of  zeros  and  some  small  frequencies.  In 
fact,  calculating  the  ratio  of  the  squared  root  of  MSE 
(RMSE) and the mean of the true observed frequency, it is 
possible  to  see that  among  all  subtypes,  CD4  is  the  one 
with poorest performance (Figure 3). KNNR did not appear 
in  any  case  to  be  among  the  top  performing  models. 
Although  this  simple  algorithm  works  well  in  some 
contexts, 
in  very  high 
dimensional spaces with few samples like in our problem. 

it  usually  performs  worse 

Figure 3. Root Mean Square Error relative to mean value of the 
response in the test set. 

 

We also calculated the correlation between the predicted 
values and the observed values for both the training and 
the test set. The correlations in the training set are strong, 
and  some  models  not  finally  reported  here  presented 
even higher correlations. However, in the test set they are 

4 

USING DNA METHYLATION TO PREDICT WHITE BLOOD CELLS FREQUENCIES IN 

TUMOR TISSUE SAMPLES 

CS 229 â€“ FINAL PROJECT WRITE-UP â€“ FALL 2015 

 
 
 
 

Marcos M. Prunello 

Ying-Cheng Chris Lee 

Biomedical Informatics MS Student 

Electrical Engineering MS Student 

marcosp@stanford.edu 

leechris@stanford.edu 

Abstract 

Large  multi-cancer  data  sets  are  available  that  profile  the  epigenome  for  tumor  tissue  samples. 
However, such cancer samples are made up of a mixture of cell types and it is necessary to determine 
to which extent the samples are composed by tumor cells or by other cell types, such as blood cells. 
We built models that are able to estimate the frequency of different types of blood cells present 
in brain tumor tissue samples using only DNA methylation data registered on the samples, and 
marked the most important genes for this task. 

 
INTRODUCTION 

Cancer refers to a group of diseases characterized by an 
uncontrolled growth in cells which can extend to different 
parts  of  the  body,  generally  caused  by  changes  in  DNA. 
There  are  about  14.1  million  new  cases  per  year  in  the 
world and it causes about 14.6% of all human deaths. In 
the United States, the financial costs of cancer have been 
estimated  at  $1.16  trillion  dollars  per  year.  There  are 
many  different  types  of  cancers,  each  with  its  own 
subtypes.  

The  importance  of  epigenomics  when  studying  cancer 
cannot  be  understated.  Epigenomics  is  the  study  of 
epigenetic modifications, which include all the variations 
that  affect  gene  expression  without  altering  the  DNA 
sequence. Changes on top of DNA have shown to activate 
oncogenes  or  deactivate  tumor  suppressor  genes.  Large 
multi-cancer data sets are now available that profile the 
epigenome for tumor tissue samples. Nevertheless, such 
cancer  samples  are  made  up  of  a  mixture  of  cell  types. 
Mathematical  approaches  are  needed  to  deconvolve 
these  mixtures  and  determine  to  which  extent  the 
samples  are  composed  by  tumor  cells  or  by  other  cell 
types, such as blood cells. 

DNA  methylation,  an  epigenetic  process  consisting  of  a 
chemical  modification  of  DNA,  is  responsible  for  cellular 
differentiation  and  hence  can  be  used  to  distinguish 
distinct cell lineages.  

Our goal in this project was to predict the  proportion of 
different  blood  cell  types  in  tumor  tissue  samples  (our 
continuous  response)  using  DNA  methylation  data 
measured  for  an  extensive  set  of  genes  (our  predictors, 
also continuous), and to identify which are the genes (the 
features) that are most important for this prediction task. 
To  achieve  this,  we  tried  several  machine 
learning 
methods:  linear  regression  with  penalization,  K-nearest 

 

1 

neighbors, support vector regression and regression trees 
(basic  trees,  but  also  random  forests,  bagging  and 
boosting). 

 

RELATED WORK 

The  use  of  methylation  signatures  to  estimate  the 
distribution  of  blood  cell  types  in  a  sample  is  called 
deconvolution of DNA methylation and it involves learning 
the specific methylation signature of each cell type from a 
set  of  samples  of  purified  known  cell  subtypes 
representing gold-standard data, to later infer the type of 
cells present in the target samples. Some research in this 
topic  has  been  carried  out  lately,  but  it  stills  remains  a 
non-trivial problem with no clear solution. Houseman [1] 
described  a  method  which 
regression 
calibration,  where  a  methylation  signature  is  considered 
to  be  a  high  dimensional  multivariate  surrogate  for  the 
distribution  of  blood  cells.  Jaffe  [2]  tailored  Housemanâ€™s 
method  using  a  new  reference  set  produced  with  450k 
microarrays instead of 27k that was published by Reinius 
[3]. 

resembles 

In  a  first  stage  of  our  work  we  applied  Housemanâ€™s 
method in the same way as Jaffe. Since this method was 
developed  for  DNA  methylation  deconvolution  in  blood 
samples but we applied it in tissue samples, we looked for 
some  way  of  validation  of  these  results.  We  decided  to 
perform  gene  expression  deconvolution  on  the  same 
samples  with  a  well  established  and  validated  method, 
Cibersort  [4].  We  found  no  match  between  our  results 
from  the  deconvolution  of  DNA  methylation  and  those 
from  Cibersortâ€™s  gene  expression  deconvolution.  Facing 
these  negative  results,  we  decided  to  approach  the 
problem as described in the introduction, using the DNA 
methylation  data  to  predict  the  frequencies  of  the 
different  blood  cell  types,  using  as  ground  truth  the 

frequencies  provided  by  Cibersort  through 
expression deconvolution. 

its  gene 

 

DATA SET AND FEATURES 

Gliobastoma cancer data 

We decided to focus our analysis in Glioblastoma (GBM), 
which is the most common and most aggressive malignant 
primary brain tumor. We extracted methylation  data for 
GBM  cancer  samples  from  The  Cancer  Genome  Atlas 
(TCGA).  Illumina  Infinium  HumanMethylation  27k  were 
used to produce TCGAâ€™s DNA methylation  data, which is 
quantified  with  beta  values  in  a  range  from  0  to  1 
representing the proportion of methylation signal  versus 
total signal. Values close to 1 represent high levels of DNA 
methylation and values  close to 0 low levels. Those CpG 
sites  with  more  than  10%  missing  values  in  all  samples 
were  removed  and  15-K  Nearest  Neighbor 
(KNN) 
algorithm  was  applied  to  estimate  the  rest  of  missing 
values [5]. TCGA samples were analyzed in batches so we 
used  Combat  to  adjust  for  this  effect  [6].  We  also 
extracted matched gene expression  data, produced with 
microarrays  technology.  Data  was 
log-transformed, 
infinities were replaced with a low value and missing value 
estimation  and  batch  correction  were  applied  as 
described  before.  The  final  data  set  consisted  of  321 
samples. 

Response features 

In  our  prediction  task, the  response  is  the  proportion  of 
seven  different  blood  cell  types  in  the  tumor  tissue 
samples: D4+ T cells, CD8+ T cells, CD56+ NK cells, CD19+ 
B  cells,  CD14+  monocytes,  neutrophils,  and  eosinophils. 
We generated our response features using Cibersort  [4], 
an  algorithm  for  gene  expression  deconvolution  which 
accurately  quantifies  the  relative  levels  of  distinct  cell 
types within a complex gene expression admixture. Such 
mixtures  can  derive  from  malignant  or  normal  solid 
tissues. 

Predictors 

Our predictors are the  methylation measurements (beta 
values)  on  a  total  of  17812  genes  for  each  of  the  321 
samples.  With  this  data  set,  we  faced  two  challenges. 
First, methylation data is known to be noisy, and second, 
we  needed  to  reduce  the  number  of  available  features 
(genes) though doing some sort of variable selection. We 
decided to approach these two issues analyzing the set of 
predictors with an algorithm called MethylMix [7], which 
identifies  hypo-  and  hyper-methylated  genes  in  cancer 
samples that are also predictive of transcription through 
the following three steps (Figure 1). 

First, for each gene a beta mixture model is fitted to the 
methylation  beta  values  to  generate  subgroups  of 

 

the 

samples  with  similar  DNA  methylation  levels,  using  an 
Expectation Maximization algorithm for mixtures of beta 
distributions (since beta-values represent the proportion 
of  methylation).  Starting  with  a  model  with  only  one 
component,  a  new  beta  mixture  component  is  added 
iteratively if it improves the fit of the model according to 
Information  Criterion  (BIC)  for  model 
the  Bayesian 
selection.  Each  of 
final  mixture  components 
represents  a  subset  of  patients  with  a  common 
methylation profile (a â€œmethylation stateâ€).  Secondly, for 
each of these subgroups the difference between its mean 
methylation  and  the  mean  methylation  in  normal  tissue 
samples 
it 
is  called  DM-value 
(Differential  Methylation).  Only 
those  genes  with 
significant  DM-values  are  selected  for  the  third  step,  in 
which a linear regression is used to model the expression 
of  each  gene  by  its  own  methylation.  If  there  is  a 
significant negative association between methylation and 
gene  expression,  the  gene 
is  finally  reported  as  a 
methylation-driven genes. 

is  calculated  and 

Figure  1.  Representation  of  MethylMix  algorithm.  This  is  a 
methylation-driven  gene  because  it  shows  methylation  states 
that  differ  from  variation  in  normal  samples  and  also  its 
methylation  profile  has  an  effect  in  gene  expression.  Each 
sample  receives  a  DM  value,  which  is  the  difference  between 
mean methylation in its group and mean methylation in normal 
samples. 

l

 
)
s
e
p
m
a
s
 
#
(
 

y
c
n
e
u
q
e
r
F

MET in normal samples 

DM VALUE 

0 

Beta-value (methylation) 

1 

 

n
o
i
s
s
e
r
p
x
E
e
n
e
G

 

            

 

Beta-value (methylation) 

 

Applying this algorithm to the GBM data, from the original 
set of 17812 genes we identified 455 methylation-driven 
genes  which  constituted  our  reduced  set  of  predictors. 

2 

Furthermore,  each  sample  for  each  gene  can  be 
represented  by  the  DM-value  of  the  group  to  which 
belongs, in addition to its original raw methylation value 
(beta  value).  DM-values  were  shown  to  perform  better 
than  raw  methylation  in  some  scenarios,  provided  that 
they constitute a less noisy version of the data [8]. In this 
way,  we  had  two  matrices  of  predictors,  one  with  the 
original methylation values and other with the DM-values, 
for  each  of  the  455  MethylMix  genes  (Figure  2).  We 
trained our predictive models in both. 

Figure 2. Heatmaps of the 321 samples and 455 genes for both 
raw data and DM-values 

Raw beta values 

Genes 

DM-values 

l

 
s
e
p
m
a
S

l

 
s
e
p
m
a
S

evaluated  the  performance  with  Mean  Squared  Error 
(MSE).  All  the  analysis  were  performed  in  R  [9].  In  the 
following paragraphs we described the methods that we 
used. In  

K-Nearest Neighbors Regression (KNNR) 

Given a value for K and a prediction point, KNNR identifies 
the  K training  observations  that  are  closest  to  the given 
point  and  predicts  its  response  with  the  average  of  the 
response  of  the  K  closest  data  points.  This  is  a  non-
parametric method. The optimal number K was selected 
with 10 fold CV. This method was implemented with the R 
package â€œcaretâ€ [10]. 

Linear regression with L1 norm penalization 

This method, also known as LASSO, fits a penalized linear 
regression  model,  where  the  coefficients  are  penalized 
using  L1  norm.  This  forces  some  of  the  coefficient 
estimates to be zero when the tuning parameter ğœ† is large 
enough. Hence, this model is in itself a variable selection 
method, yielding a sparse model, very convenient in our 
application provided that we have 455 predictors and 321 
samples. The objective function being minimized is: 

ğ‘›

ğ‘š
âˆ‘ (ğ‘¦ğ‘– âˆ’ ğ›½0 âˆ’ âˆ‘ ğ›½ğ‘—ğ‘¥ğ‘–ğ‘—
ğ‘–=1

ğ‘—=1

2

ğ‘›

 )

+ ğœ† âˆ‘ |ğ›½ğ‘—|
 

ğ‘—=1

(1) 

We selected the penalization parameter ğœ† with 10 fold CV. 
This  method  was  implemented  using  the  R  package 
â€œglmnetâ€ [11]. 

Support Vector Regression (SVR) 

SVR is an extension of Support Vector Machines (SVM) for 
cases where the response is continuous instead of binary. 
SVR contains all the main features that characterize SVM, 
with a loss function that ignores errors situated within a 
certain distance of the true value. This type of function is 
often called epsilon intensive loss function, since a margin 
of tolerance ğœ– is set. The dual representation of the model 
is given by: 

Genes 

1
2

min

ğ›¼

 

(ğ›¼ âˆ’ ğ›¼ âˆ—)ğ‘‡ğ‘„(ğ›¼ âˆ’ ğ›¼ âˆ—) + ğœ– âˆ‘(ğ›¼ğ‘– + ğ›¼ğ‘–

âˆ— )

+ âˆ‘ ğ‘¦ğ‘–(ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

âˆ— )

 

ğ‘š

ğ‘š

ğ‘–=1

ğ‘–=1

(2) 

 

METHODS 

We  divided  our  321  samples  into  one  training  set  (80%) 
and  one  test  set  (20%).  We  trained  several  machine 
learning methods to predict the frequencies of each of the 
7  blood  cell  subtypes  individually,  using  both  the  raw 
methylation  and  the  DM-values  training  sets.  We  tuned 
the  parameters  required  for  each  method  with  10-fold 
cross  validation  (CV),  and  once  selected  the  optimal 
parameters, we refitted the model in the whole training 
set. Finally, we predicted the response in the test set, and 

 

such that: 0 â‰¤   ğ›¼ğ‘–, ğ›¼ğ‘–

âˆ— â‰¤ ğ¶, ğ‘– = 1, â€¦ , ğ‘š, âˆ‘ (ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

ğ‘™
ğ‘–=1

âˆ— )

= 0 

positive 

where ğ¶ is the upper bound for the cost parameter, ğ‘„ is 
an  ğ‘šğ‘¥ğ‘š 
semidefinite  matrix,  ğ‘„ğ‘–ğ‘— =
ğ‘¦ğ‘–ğ‘¦ğ‘—ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—), ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—) = ğœ™(ğ‘¥ğ‘–)ğ‘‡ğœ™(ğ‘¥ğ‘—) is a kernel and ğ‘š 
is the number of observations. We implemented SVR with 
radial or polynomial kernel, but also with no kernel at all 
(Table  1).  In  each  case,  the  required  parameters  were 
selected with 10 fold CV. SVR was implemented with the 
R package â€œe1071â€ [12]. 

 

3 

Table 1. Kernels applied in SVR 

Kernel 

Formula 

Linear 
Radial 

ğ‘¢ğ‘‡ğ‘£ 

2
exp (âˆ’ğ›¾||ğ‘¢ âˆ’ ğ‘£||

 ) 

Polynomial 

ğ›¾(ğ‘¢ğ‘‡ğ‘£)ğ‘‘ 

Parameters 

tuned with CV 

ğ¶, ğœ– 
ğ¶, ğœ–, ğ›¾ 

ğ¶, ğœ–, ğ›¾, ğ‘‘ 

 

Tree-based methods 

to 

improve 

these  approaches 

forests,  and  boosting 

Tree-based  methods  for  regression  involve  segmenting 
the predictor space into a number of simple regions and 
using the mean of the training observations in the region 
to which a point that we want to predict belongs. We first 
fitted a basic regression tree and pruned it with 10 fold CV. 
Since  basic  regression  trees  do  not  always  provide  the 
best results in terms of accuracy, we also applied bagging, 
random 
the 
performance.  Each  of 
involves 
producing multiple trees which are then combined to yield 
a single prediction. Bagging takes B bootstrap samples of 
the  training  observations,  fits  several  regression  trees 
then averages the predicted values, helping to reduce the 
characteristic  high  variance  in  a  basic  regression  tree. 
Random trees contributes to decorrelate the trees built by 
bagging, by taking a random sample of some predictors as 
split candidates each time a split in a tree is considered. 
Boosting  is  another  which  in  the  context  of  regression 
trees involves growing the trees sequentially, each tree is 
grown using information from previously grown trees. The 
number  of  trees  as  well  as  other  parameters  like  the 
number of predictors chosen randomly in random forests 
were  optimized 
looking  at  out-of-bag  (OOB)  error 
estimates.  We  used  the  R  packages  â€œtreeâ€  [13], 
â€œrandomForestsâ€ [14] and â€œgbmâ€ [15]. 

 

RESULTS 

A  total  of  126  models  were  trained,  given  our  7  cell 
subtypes,  2  data  types,  and  9  candidate  models  (KNNR, 
Lasso,  SVR  with  3  different  kernels  and  4  tree-based 
methods).  After  optimizing  the  parameters  for  each 
model with 10 fold CV, the model was re fit in the whole 
training  set  and  predictions  were  obtained  for  both  the 
training and the independent test set.  Then we calculated 
different measurements  to  evaluate  the  performance  of 
the model but we used the traditional Mean Square Error 
(MSE) on the test set to select the best performing model 
for each subtype (Table 2). 

Looking not only at the best performing model but also to 
the top models for each cell subtype, we did not find that 
either  the  raw  methylation  data  or  the  DM-values 
outperformed the other data type in most cases. Although 
we  hypothesized  that  the  DM-values  could  performed 
better as they represent a de-noised version of the data, 

 

it seems that the raw methylation data was enough for the 
prediction task. 

Table 2. Top performing model for each cell subtype 

Subtype 

B cells 
CD4 
CD8 
Eos 
Mon 
Neu 
NK 

Best Model 

Obs 
Mean 
0.0941  Raw - SVR Lin 
0.0045  Raw - Lasso 
0.1733  DM -Rand Forests 
0.1404  Raw - Boosting 
0.2449  DM - SVR Linear 
0.0547  Raw - SVR Radial 
0.2882  Raw - SVR Polyn 

MSE 
Test 
0.0043 
0.0007 
0.0181 
0.0045 
0.0095 
0.0143 
0.0053 

MSE 
Train 
0.002 
0.0003 
0.0032 
0.0039 
0.0089 
0.0076 
0.0038 

Cor 
Test 
0.545 
0.3907 
0.3948 
0.1286 
0.2716 
0.4331 
0.6236 

Cor 
Train 
0.7915 
0.8812 
0.9877 
0.559 
0.6221 
0.8581 
0.7769 

They 

the  best. 

In terms of the models, different methods worked better 
for different cell subtypes, but in 4 out of the 7 subtypes 
it was support vector regression the one that achieved the 
best results. For B cells and Monocytes, the best model did 
not  require  any  kernel,  whereas  for  Neutrophils  and 
Natural  Killers  used  a  radial  or  a  polynomial  kernel, 
respectively. For CD8 and Eosinophils, random forests and 
boosting  performed 
represent 
improvements over the basic regression tree, since both 
fit several trees. Random forests takes random samples of 
the  predictors  to  make  a  final  prediction  using  not  very 
correlated  trees,  and  boosting in  each  new  tree weights 
more those points with bigger errors in the previous trees, 
so  it  is  reasonable  to  see  that  these  methods  worked 
better  than  the  basic  regression  tree.  For  CD4,  the  best 
performing model is LASSO. Nevertheless, results for CD4 
should  be  interpreted  with  care,  since  the  frequency  of 
CD4  in  the  samples is  very  low  and the response  vector 
consists  mainly  of  zeros  and  some  small  frequencies.  In 
fact,  calculating  the  ratio  of  the  squared  root  of  MSE 
(RMSE) and the mean of the true observed frequency, it is 
possible  to  see that  among  all  subtypes,  CD4  is  the  one 
with poorest performance (Figure 3). KNNR did not appear 
in  any  case  to  be  among  the  top  performing  models. 
Although  this  simple  algorithm  works  well  in  some 
contexts, 
in  very  high 
dimensional spaces with few samples like in our problem. 

it  usually  performs  worse 

Figure 3. Root Mean Square Error relative to mean value of the 
response in the test set. 

 

We also calculated the correlation between the predicted 
values and the observed values for both the training and 
the test set. The correlations in the training set are strong, 
and  some  models  not  finally  reported  here  presented 
even higher correlations. However, in the test set they are 

4 

weaker,  showing  that  there is room  for improvement  in 
the  predictions.  Even  though  we  selected  our  reduced 
feature set independently of the response, there might be 
some  overfitting  in  our  models,  considering  as  well  that 
the  number  of  predictors  is  still  high  in  relation  to  the 
number of samples. 

We  identified  for  each  subtype  which  were  the  most 
important  genes  in  the  top  performing  model  and  we 
report  here  the  top  5.  Again,  results  for  CD4  should  be 
interpreted with  care,  since  the  performance  was weak, 
and also because the L1 penalty of the LASSO forces some 
coefficients to be zero, and if there are some correlated 
genes, arbitrarily one is kept as a non-zero coefficient and 
the others become zero. We intersected the top 30 genes 
for  each  subtype  and  found  that  there  were  no  genes 
pointed as important in most subtypes simultaneously. 

 
Table 3. Top performing model for each cell subtype. 

Subtype 
B cells 
CD4 
CD8 
Eos 
Mon 
Neu 
NK 

 

Top 5 important genes 

HSD17B14  ZNF329  PLA2R1  MT2A 
ABHD8  ACAA2 
ABCA5 
ACN9 
TNFRSF1A  KLHL26  PSMB8 
CTSZ 
CRYBB1 
KLHL34 
NETO1 
ZNF549 

DDX43  C17orf76  ACSBG1  ANKRD9 
ZNF135 
SMOC1  RDH5 
CABYR 
FOXD1 
STAG3  ME1 
CTHRC1 
BCL11A  C9orf95 
ZNF781  DUSP23 

PDGFRA 
ACOT4 
OAS1 

The  resultant  top  frequency  predictive  genes  suggests 
some primitive principles. The fact that very few top gene 
overlaps  between  different  white  blood  cell  types 
suggests  very  differentiated  activities  between  the  cell 
types. It is possible to see that each cell types' top genes 
seem to showcase execute main and various biochemical 
tasks known to be specific to that particular cell type, for 
example, CRYBB1 beta-crystallin B1 for Eosinophils known 
having crystalloid core, and others. On the context of gene 
regulation, each cell types contain one top gene that is of 
DNA-binding functionality: ZNF329 for B cells, ABCA5 for 
CD4+ T cells, OAS1 for CD8+ T cells, DDX43 for Eosinophils, 
ZNF135  for  Monocytes,  ME1,  STAG3  and  FOXD1  for 
Neutrophils,  ZNF549  and  ZNF781  for  Natural  Killer  cell. 
These  might  be  of  interest  for  implications  on  gene 
regulations.  On 
tumor 
immunological  functions  or  apoptotic  function,  a  few 
genes  stand  out:  TNFRSF1A,  tumor  necrosis  factor 
superfamily 1A for CD8+ T cells, ANKRD9, Ankyrin repeat 
domain-containing  protein  9  for  Eosinophils,  STAG3, 
cohesin  subunit  SA-3  for  Neutrophils,  BCL11A,  B  cell 
CLL/lymphoma 11A isoform2 for Natural Killer cells. These 
may  be  of 
implications  on  cancer 
immnological functions. Finally a few top genes appear to 
be less annotated with Gene Ontology terms: C17orf76 for 
Eosinophils,  KLH34  for  Monocytes,  C9orf95  and  ZNF781 
for Natural Killer cells.  These might  be  genes  with  novel 
implications. 

the  context  of  possible 

interest 

for 

DISCUSSION AND CONCLUSION 

In this project we built models that are able to predict the 
frequency  of  7  blood  cell  subtypes  (D4+  T  cells,  CD8+  T 
cells,  CD56+  NK  cells,  CD19+  B  cells,  CD14+  monocytes, 
neutrophils, and eosinophils) in samples from brain tumor 
tissue  using  only  DNA  methylation  data.  We  applied  an 
algorithm  which  identifies  methylation  driven  genes  to 
select  a  reduced  feature  space,  and  trained  our  models 
with both raw methylation data and DM-values. Although 
we  suspected  that  the  DM-values  would  show  a  better 
performance as they constitute de-noised data, in 5 out of 
the 7 subtypes, the best model used the raw data. 

In  relation  to  the  performance  of  the  models,  support 
vector  regression  performed  was  selected  as  the  best 
model  for  4  subtypes,  although  with  different  kernels. 
Probably  the  ability  of  SVR  to  work  in  high  dimensional 
spaces  contributed  to  this  outstanding  performance.  In 
two cases the best model was a tree-based method and in 
one the penalized linear regression. KNN was not picked 
as one of the best models, this simple method is known 
not to perform very well in highly dimensional spaces, and 
hence our higher number of predictors than samples may 
not be most adequate context for KNN. 

From the inspection of the results, it is clear that there is 
wide opportunity for improvement of the performance of 
this  prediction  task.  For  example,  our  feature  selection 
with MethylMix was carried out independently from the 
response;  a  future  modification  should  explore  in  more 
detail the set of 17812 genes with some variable selection 
procedure that also involves the response. Furthermore, 
we did not account for the fact that our response was a 
proportion, ranging from 0 to 1, and the addition of this 
constraint may  strengthen  our  models, for  example,  the 
linear regression  model  which  as  it  is can predict  values 
outside of the plausible range.  

Other aspect of this problem that should be addressed is 
the 
joint  prediction  of  our  7  responses,  and  not 
individually  as  we  did.  Since  the  relative  frequencies  of 
each  cell  subtype  are  related  to  each  other,  it  seems 
reasonable to predict all the frequencies together with a 
multivariate  response.  Also,  we  acknowledge  that  our 
data  set  was  rather  small,  321  samples  divided  into  the 
training  and  test  sets.  We  would  like  to  evaluate  the 
results of our work in larger data sets, from other types of 
tumor as well. 

Even though this work can be further extended with the 
suggestions  previously  mentioned,  we  were  able  to  see 
that DNA methylation provides clear signal of the immune 
composition of the tumor tissue and can be used to infer 
the relative frequencies of different types of white blood 
cells present in the samples. 

 

5 

 

USING DNA METHYLATION TO PREDICT WHITE BLOOD CELLS FREQUENCIES IN 

TUMOR TISSUE SAMPLES 

CS 229 â€“ FINAL PROJECT WRITE-UP â€“ FALL 2015 

 
 
 
 

Marcos M. Prunello 

Ying-Cheng Chris Lee 

Biomedical Informatics MS Student 

Electrical Engineering MS Student 

marcosp@stanford.edu 

leechris@stanford.edu 

Abstract 

Large  multi-cancer  data  sets  are  available  that  profile  the  epigenome  for  tumor  tissue  samples. 
However, such cancer samples are made up of a mixture of cell types and it is necessary to determine 
to which extent the samples are composed by tumor cells or by other cell types, such as blood cells. 
We built models that are able to estimate the frequency of different types of blood cells present 
in brain tumor tissue samples using only DNA methylation data registered on the samples, and 
marked the most important genes for this task. 

 
INTRODUCTION 

Cancer refers to a group of diseases characterized by an 
uncontrolled growth in cells which can extend to different 
parts  of  the  body,  generally  caused  by  changes  in  DNA. 
There  are  about  14.1  million  new  cases  per  year  in  the 
world and it causes about 14.6% of all human deaths. In 
the United States, the financial costs of cancer have been 
estimated  at  $1.16  trillion  dollars  per  year.  There  are 
many  different  types  of  cancers,  each  with  its  own 
subtypes.  

The  importance  of  epigenomics  when  studying  cancer 
cannot  be  understated.  Epigenomics  is  the  study  of 
epigenetic modifications, which include all the variations 
that  affect  gene  expression  without  altering  the  DNA 
sequence. Changes on top of DNA have shown to activate 
oncogenes  or  deactivate  tumor  suppressor  genes.  Large 
multi-cancer data sets are now available that profile the 
epigenome for tumor tissue samples. Nevertheless, such 
cancer  samples  are  made  up  of  a  mixture  of  cell  types. 
Mathematical  approaches  are  needed  to  deconvolve 
these  mixtures  and  determine  to  which  extent  the 
samples  are  composed  by  tumor  cells  or  by  other  cell 
types, such as blood cells. 

DNA  methylation,  an  epigenetic  process  consisting  of  a 
chemical  modification  of  DNA,  is  responsible  for  cellular 
differentiation  and  hence  can  be  used  to  distinguish 
distinct cell lineages.  

Our goal in this project was to predict the  proportion of 
different  blood  cell  types  in  tumor  tissue  samples  (our 
continuous  response)  using  DNA  methylation  data 
measured  for  an  extensive  set  of  genes  (our  predictors, 
also continuous), and to identify which are the genes (the 
features) that are most important for this prediction task. 
To  achieve  this,  we  tried  several  machine 
learning 
methods:  linear  regression  with  penalization,  K-nearest 

 

1 

neighbors, support vector regression and regression trees 
(basic  trees,  but  also  random  forests,  bagging  and 
boosting). 

 

RELATED WORK 

The  use  of  methylation  signatures  to  estimate  the 
distribution  of  blood  cell  types  in  a  sample  is  called 
deconvolution of DNA methylation and it involves learning 
the specific methylation signature of each cell type from a 
set  of  samples  of  purified  known  cell  subtypes 
representing gold-standard data, to later infer the type of 
cells present in the target samples. Some research in this 
topic  has  been  carried  out  lately,  but  it  stills  remains  a 
non-trivial problem with no clear solution. Houseman [1] 
described  a  method  which 
regression 
calibration,  where  a  methylation  signature  is  considered 
to  be  a  high  dimensional  multivariate  surrogate  for  the 
distribution  of  blood  cells.  Jaffe  [2]  tailored  Housemanâ€™s 
method  using  a  new  reference  set  produced  with  450k 
microarrays instead of 27k that was published by Reinius 
[3]. 

resembles 

In  a  first  stage  of  our  work  we  applied  Housemanâ€™s 
method in the same way as Jaffe. Since this method was 
developed  for  DNA  methylation  deconvolution  in  blood 
samples but we applied it in tissue samples, we looked for 
some  way  of  validation  of  these  results.  We  decided  to 
perform  gene  expression  deconvolution  on  the  same 
samples  with  a  well  established  and  validated  method, 
Cibersort  [4].  We  found  no  match  between  our  results 
from  the  deconvolution  of  DNA  methylation  and  those 
from  Cibersortâ€™s  gene  expression  deconvolution.  Facing 
these  negative  results,  we  decided  to  approach  the 
problem as described in the introduction, using the DNA 
methylation  data  to  predict  the  frequencies  of  the 
different  blood  cell  types,  using  as  ground  truth  the 

frequencies  provided  by  Cibersort  through 
expression deconvolution. 

its  gene 

 

DATA SET AND FEATURES 

Gliobastoma cancer data 

We decided to focus our analysis in Glioblastoma (GBM), 
which is the most common and most aggressive malignant 
primary brain tumor. We extracted methylation  data for 
GBM  cancer  samples  from  The  Cancer  Genome  Atlas 
(TCGA).  Illumina  Infinium  HumanMethylation  27k  were 
used to produce TCGAâ€™s DNA methylation  data, which is 
quantified  with  beta  values  in  a  range  from  0  to  1 
representing the proportion of methylation signal  versus 
total signal. Values close to 1 represent high levels of DNA 
methylation and values  close to 0 low levels. Those CpG 
sites  with  more  than  10%  missing  values  in  all  samples 
were  removed  and  15-K  Nearest  Neighbor 
(KNN) 
algorithm  was  applied  to  estimate  the  rest  of  missing 
values [5]. TCGA samples were analyzed in batches so we 
used  Combat  to  adjust  for  this  effect  [6].  We  also 
extracted matched gene expression  data, produced with 
microarrays  technology.  Data  was 
log-transformed, 
infinities were replaced with a low value and missing value 
estimation  and  batch  correction  were  applied  as 
described  before.  The  final  data  set  consisted  of  321 
samples. 

Response features 

In  our  prediction  task, the  response  is  the  proportion  of 
seven  different  blood  cell  types  in  the  tumor  tissue 
samples: D4+ T cells, CD8+ T cells, CD56+ NK cells, CD19+ 
B  cells,  CD14+  monocytes,  neutrophils,  and  eosinophils. 
We generated our response features using Cibersort  [4], 
an  algorithm  for  gene  expression  deconvolution  which 
accurately  quantifies  the  relative  levels  of  distinct  cell 
types within a complex gene expression admixture. Such 
mixtures  can  derive  from  malignant  or  normal  solid 
tissues. 

Predictors 

Our predictors are the  methylation measurements (beta 
values)  on  a  total  of  17812  genes  for  each  of  the  321 
samples.  With  this  data  set,  we  faced  two  challenges. 
First, methylation data is known to be noisy, and second, 
we  needed  to  reduce  the  number  of  available  features 
(genes) though doing some sort of variable selection. We 
decided to approach these two issues analyzing the set of 
predictors with an algorithm called MethylMix [7], which 
identifies  hypo-  and  hyper-methylated  genes  in  cancer 
samples that are also predictive of transcription through 
the following three steps (Figure 1). 

First, for each gene a beta mixture model is fitted to the 
methylation  beta  values  to  generate  subgroups  of 

 

the 

samples  with  similar  DNA  methylation  levels,  using  an 
Expectation Maximization algorithm for mixtures of beta 
distributions (since beta-values represent the proportion 
of  methylation).  Starting  with  a  model  with  only  one 
component,  a  new  beta  mixture  component  is  added 
iteratively if it improves the fit of the model according to 
Information  Criterion  (BIC)  for  model 
the  Bayesian 
selection.  Each  of 
final  mixture  components 
represents  a  subset  of  patients  with  a  common 
methylation profile (a â€œmethylation stateâ€).  Secondly, for 
each of these subgroups the difference between its mean 
methylation  and  the  mean  methylation  in  normal  tissue 
samples 
it 
is  called  DM-value 
(Differential  Methylation).  Only 
those  genes  with 
significant  DM-values  are  selected  for  the  third  step,  in 
which a linear regression is used to model the expression 
of  each  gene  by  its  own  methylation.  If  there  is  a 
significant negative association between methylation and 
gene  expression,  the  gene 
is  finally  reported  as  a 
methylation-driven genes. 

is  calculated  and 

Figure  1.  Representation  of  MethylMix  algorithm.  This  is  a 
methylation-driven  gene  because  it  shows  methylation  states 
that  differ  from  variation  in  normal  samples  and  also  its 
methylation  profile  has  an  effect  in  gene  expression.  Each 
sample  receives  a  DM  value,  which  is  the  difference  between 
mean methylation in its group and mean methylation in normal 
samples. 

l

 
)
s
e
p
m
a
s
 
#
(
 

y
c
n
e
u
q
e
r
F

MET in normal samples 

DM VALUE 

0 

Beta-value (methylation) 

1 

 

n
o
i
s
s
e
r
p
x
E
e
n
e
G

 

            

 

Beta-value (methylation) 

 

Applying this algorithm to the GBM data, from the original 
set of 17812 genes we identified 455 methylation-driven 
genes  which  constituted  our  reduced  set  of  predictors. 

2 

Furthermore,  each  sample  for  each  gene  can  be 
represented  by  the  DM-value  of  the  group  to  which 
belongs, in addition to its original raw methylation value 
(beta  value).  DM-values  were  shown  to  perform  better 
than  raw  methylation  in  some  scenarios,  provided  that 
they constitute a less noisy version of the data [8]. In this 
way,  we  had  two  matrices  of  predictors,  one  with  the 
original methylation values and other with the DM-values, 
for  each  of  the  455  MethylMix  genes  (Figure  2).  We 
trained our predictive models in both. 

Figure 2. Heatmaps of the 321 samples and 455 genes for both 
raw data and DM-values 

Raw beta values 

Genes 

DM-values 

l

 
s
e
p
m
a
S

l

 
s
e
p
m
a
S

evaluated  the  performance  with  Mean  Squared  Error 
(MSE).  All  the  analysis  were  performed  in  R  [9].  In  the 
following paragraphs we described the methods that we 
used. In  

K-Nearest Neighbors Regression (KNNR) 

Given a value for K and a prediction point, KNNR identifies 
the  K training  observations  that  are  closest  to  the given 
point  and  predicts  its  response  with  the  average  of  the 
response  of  the  K  closest  data  points.  This  is  a  non-
parametric method. The optimal number K was selected 
with 10 fold CV. This method was implemented with the R 
package â€œcaretâ€ [10]. 

Linear regression with L1 norm penalization 

This method, also known as LASSO, fits a penalized linear 
regression  model,  where  the  coefficients  are  penalized 
using  L1  norm.  This  forces  some  of  the  coefficient 
estimates to be zero when the tuning parameter ğœ† is large 
enough. Hence, this model is in itself a variable selection 
method, yielding a sparse model, very convenient in our 
application provided that we have 455 predictors and 321 
samples. The objective function being minimized is: 

ğ‘›

ğ‘š
âˆ‘ (ğ‘¦ğ‘– âˆ’ ğ›½0 âˆ’ âˆ‘ ğ›½ğ‘—ğ‘¥ğ‘–ğ‘—
ğ‘–=1

ğ‘—=1

2

ğ‘›

 )

+ ğœ† âˆ‘ |ğ›½ğ‘—|
 

ğ‘—=1

(1) 

We selected the penalization parameter ğœ† with 10 fold CV. 
This  method  was  implemented  using  the  R  package 
â€œglmnetâ€ [11]. 

Support Vector Regression (SVR) 

SVR is an extension of Support Vector Machines (SVM) for 
cases where the response is continuous instead of binary. 
SVR contains all the main features that characterize SVM, 
with a loss function that ignores errors situated within a 
certain distance of the true value. This type of function is 
often called epsilon intensive loss function, since a margin 
of tolerance ğœ– is set. The dual representation of the model 
is given by: 

Genes 

1
2

min

ğ›¼

 

(ğ›¼ âˆ’ ğ›¼ âˆ—)ğ‘‡ğ‘„(ğ›¼ âˆ’ ğ›¼ âˆ—) + ğœ– âˆ‘(ğ›¼ğ‘– + ğ›¼ğ‘–

âˆ— )

+ âˆ‘ ğ‘¦ğ‘–(ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

âˆ— )

 

ğ‘š

ğ‘š

ğ‘–=1

ğ‘–=1

(2) 

 

METHODS 

We  divided  our  321  samples  into  one  training  set  (80%) 
and  one  test  set  (20%).  We  trained  several  machine 
learning methods to predict the frequencies of each of the 
7  blood  cell  subtypes  individually,  using  both  the  raw 
methylation  and  the  DM-values  training  sets.  We  tuned 
the  parameters  required  for  each  method  with  10-fold 
cross  validation  (CV),  and  once  selected  the  optimal 
parameters, we refitted the model in the whole training 
set. Finally, we predicted the response in the test set, and 

 

such that: 0 â‰¤   ğ›¼ğ‘–, ğ›¼ğ‘–

âˆ— â‰¤ ğ¶, ğ‘– = 1, â€¦ , ğ‘š, âˆ‘ (ğ›¼ğ‘– âˆ’ ğ›¼ğ‘–

ğ‘™
ğ‘–=1

âˆ— )

= 0 

positive 

where ğ¶ is the upper bound for the cost parameter, ğ‘„ is 
an  ğ‘šğ‘¥ğ‘š 
semidefinite  matrix,  ğ‘„ğ‘–ğ‘— =
ğ‘¦ğ‘–ğ‘¦ğ‘—ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—), ğ¾(ğ‘¥ğ‘–, ğ‘¥ğ‘—) = ğœ™(ğ‘¥ğ‘–)ğ‘‡ğœ™(ğ‘¥ğ‘—) is a kernel and ğ‘š 
is the number of observations. We implemented SVR with 
radial or polynomial kernel, but also with no kernel at all 
(Table  1).  In  each  case,  the  required  parameters  were 
selected with 10 fold CV. SVR was implemented with the 
R package â€œe1071â€ [12]. 

 

3 

Table 1. Kernels applied in SVR 

Kernel 

Formula 

Linear 
Radial 

ğ‘¢ğ‘‡ğ‘£ 

2
exp (âˆ’ğ›¾||ğ‘¢ âˆ’ ğ‘£||

 ) 

Polynomial 

ğ›¾(ğ‘¢ğ‘‡ğ‘£)ğ‘‘ 

Parameters 

tuned with CV 

ğ¶, ğœ– 
ğ¶, ğœ–, ğ›¾ 

ğ¶, ğœ–, ğ›¾, ğ‘‘ 

 

Tree-based methods 

to 

improve 

these  approaches 

forests,  and  boosting 

Tree-based  methods  for  regression  involve  segmenting 
the predictor space into a number of simple regions and 
using the mean of the training observations in the region 
to which a point that we want to predict belongs. We first 
fitted a basic regression tree and pruned it with 10 fold CV. 
Since  basic  regression  trees  do  not  always  provide  the 
best results in terms of accuracy, we also applied bagging, 
random 
the 
performance.  Each  of 
involves 
producing multiple trees which are then combined to yield 
a single prediction. Bagging takes B bootstrap samples of 
the  training  observations,  fits  several  regression  trees 
then averages the predicted values, helping to reduce the 
characteristic  high  variance  in  a  basic  regression  tree. 
Random trees contributes to decorrelate the trees built by 
bagging, by taking a random sample of some predictors as 
split candidates each time a split in a tree is considered. 
Boosting  is  another  which  in  the  context  of  regression 
trees involves growing the trees sequentially, each tree is 
grown using information from previously grown trees. The 
number  of  trees  as  well  as  other  parameters  like  the 
number of predictors chosen randomly in random forests 
were  optimized 
looking  at  out-of-bag  (OOB)  error 
estimates.  We  used  the  R  packages  â€œtreeâ€  [13], 
â€œrandomForestsâ€ [14] and â€œgbmâ€ [15]. 

 

RESULTS 

A  total  of  126  models  were  trained,  given  our  7  cell 
subtypes,  2  data  types,  and  9  candidate  models  (KNNR, 
Lasso,  SVR  with  3  different  kernels  and  4  tree-based 
methods).  After  optimizing  the  parameters  for  each 
model with 10 fold CV, the model was re fit in the whole 
training  set  and  predictions  were  obtained  for  both  the 
training and the independent test set.  Then we calculated 
different measurements  to  evaluate  the  performance  of 
the model but we used the traditional Mean Square Error 
(MSE) on the test set to select the best performing model 
for each subtype (Table 2). 

Looking not only at the best performing model but also to 
the top models for each cell subtype, we did not find that 
either  the  raw  methylation  data  or  the  DM-values 
outperformed the other data type in most cases. Although 
we  hypothesized  that  the  DM-values  could  performed 
better as they represent a de-noised version of the data, 

 

it seems that the raw methylation data was enough for the 
prediction task. 

Table 2. Top performing model for each cell subtype 

Subtype 

B cells 
CD4 
CD8 
Eos 
Mon 
Neu 
NK 

Best Model 

Obs 
Mean 
0.0941  Raw - SVR Lin 
0.0045  Raw - Lasso 
0.1733  DM -Rand Forests 
0.1404  Raw - Boosting 
0.2449  DM - SVR Linear 
0.0547  Raw - SVR Radial 
0.2882  Raw - SVR Polyn 

MSE 
Test 
0.0043 
0.0007 
0.0181 
0.0045 
0.0095 
0.0143 
0.0053 

MSE 
Train 
0.002 
0.0003 
0.0032 
0.0039 
0.0089 
0.0076 
0.0038 

Cor 
Test 
0.545 
0.3907 
0.3948 
0.1286 
0.2716 
0.4331 
0.6236 

Cor 
Train 
0.7915 
0.8812 
0.9877 
0.559 
0.6221 
0.8581 
0.7769 

They 

the  best. 

In terms of the models, different methods worked better 
for different cell subtypes, but in 4 out of the 7 subtypes 
it was support vector regression the one that achieved the 
best results. For B cells and Monocytes, the best model did 
not  require  any  kernel,  whereas  for  Neutrophils  and 
Natural  Killers  used  a  radial  or  a  polynomial  kernel, 
respectively. For CD8 and Eosinophils, random forests and 
boosting  performed 
represent 
improvements over the basic regression tree, since both 
fit several trees. Random forests takes random samples of 
the  predictors  to  make  a  final  prediction  using  not  very 
correlated  trees,  and  boosting in  each  new  tree weights 
more those points with bigger errors in the previous trees, 
so  it  is  reasonable  to  see  that  these  methods  worked 
better  than  the  basic  regression  tree.  For  CD4,  the  best 
performing model is LASSO. Nevertheless, results for CD4 
should  be  interpreted  with  care,  since  the  frequency  of 
CD4  in  the  samples is  very  low  and the response  vector 
consists  mainly  of  zeros  and  some  small  frequencies.  In 
fact,  calculating  the  ratio  of  the  squared  root  of  MSE 
(RMSE) and the mean of the true observed frequency, it is 
possible  to  see that  among  all  subtypes,  CD4  is  the  one 
with poorest performance (Figure 3). KNNR did not appear 
in  any  case  to  be  among  the  top  performing  models. 
Although  this  simple  algorithm  works  well  in  some 
contexts, 
in  very  high 
dimensional spaces with few samples like in our problem. 

it  usually  performs  worse 

Figure 3. Root Mean Square Error relative to mean value of the 
response in the test set. 

 

We also calculated the correlation between the predicted 
values and the observed values for both the training and 
the test set. The correlations in the training set are strong, 
and  some  models  not  finally  reported  here  presented 
even higher correlations. However, in the test set they are 

4 

weaker,  showing  that  there is room  for improvement  in 
the  predictions.  Even  though  we  selected  our  reduced 
feature set independently of the response, there might be 
some  overfitting  in  our  models,  considering  as  well  that 
the  number  of  predictors  is  still  high  in  relation  to  the 
number of samples. 

We  identified  for  each  subtype  which  were  the  most 
important  genes  in  the  top  performing  model  and  we 
report  here  the  top  5.  Again,  results  for  CD4  should  be 
interpreted with  care,  since  the  performance  was weak, 
and also because the L1 penalty of the LASSO forces some 
coefficients to be zero, and if there are some correlated 
genes, arbitrarily one is kept as a non-zero coefficient and 
the others become zero. We intersected the top 30 genes 
for  each  subtype  and  found  that  there  were  no  genes 
pointed as important in most subtypes simultaneously. 

 
Table 3. Top performing model for each cell subtype. 

Subtype 
B cells 
CD4 
CD8 
Eos 
Mon 
Neu 
NK 

 

Top 5 important genes 

HSD17B14  ZNF329  PLA2R1  MT2A 
ABHD8  ACAA2 
ABCA5 
ACN9 
TNFRSF1A  KLHL26  PSMB8 
CTSZ 
CRYBB1 
KLHL34 
NETO1 
ZNF549 

DDX43  C17orf76  ACSBG1  ANKRD9 
ZNF135 
SMOC1  RDH5 
CABYR 
FOXD1 
STAG3  ME1 
CTHRC1 
BCL11A  C9orf95 
ZNF781  DUSP23 

PDGFRA 
ACOT4 
OAS1 

The  resultant  top  frequency  predictive  genes  suggests 
some primitive principles. The fact that very few top gene 
overlaps  between  different  white  blood  cell  types 
suggests  very  differentiated  activities  between  the  cell 
types. It is possible to see that each cell types' top genes 
seem to showcase execute main and various biochemical 
tasks known to be specific to that particular cell type, for 
example, CRYBB1 beta-crystallin B1 for Eosinophils known 
having crystalloid core, and others. On the context of gene 
regulation, each cell types contain one top gene that is of 
DNA-binding functionality: ZNF329 for B cells, ABCA5 for 
CD4+ T cells, OAS1 for CD8+ T cells, DDX43 for Eosinophils, 
ZNF135  for  Monocytes,  ME1,  STAG3  and  FOXD1  for 
Neutrophils,  ZNF549  and  ZNF781  for  Natural  Killer  cell. 
These  might  be  of  interest  for  implications  on  gene 
regulations.  On 
tumor 
immunological  functions  or  apoptotic  function,  a  few 
genes  stand  out:  TNFRSF1A,  tumor  necrosis  factor 
superfamily 1A for CD8+ T cells, ANKRD9, Ankyrin repeat 
domain-containing  protein  9  for  Eosinophils,  STAG3, 
cohesin  subunit  SA-3  for  Neutrophils,  BCL11A,  B  cell 
CLL/lymphoma 11A isoform2 for Natural Killer cells. These 
may  be  of 
implications  on  cancer 
immnological functions. Finally a few top genes appear to 
be less annotated with Gene Ontology terms: C17orf76 for 
Eosinophils,  KLH34  for  Monocytes,  C9orf95  and  ZNF781 
for Natural Killer cells.  These might  be  genes  with  novel 
implications. 

the  context  of  possible 

interest 

for 

DISCUSSION AND CONCLUSION 

In this project we built models that are able to predict the 
frequency  of  7  blood  cell  subtypes  (D4+  T  cells,  CD8+  T 
cells,  CD56+  NK  cells,  CD19+  B  cells,  CD14+  monocytes, 
neutrophils, and eosinophils) in samples from brain tumor 
tissue  using  only  DNA  methylation  data.  We  applied  an 
algorithm  which  identifies  methylation  driven  genes  to 
select  a  reduced  feature  space,  and  trained  our  models 
with both raw methylation data and DM-values. Although 
we  suspected  that  the  DM-values  would  show  a  better 
performance as they constitute de-noised data, in 5 out of 
the 7 subtypes, the best model used the raw data. 

In  relation  to  the  performance  of  the  models,  support 
vector  regression  performed  was  selected  as  the  best 
model  for  4  subtypes,  although  with  different  kernels. 
Probably  the  ability  of  SVR  to  work  in  high  dimensional 
spaces  contributed  to  this  outstanding  performance.  In 
two cases the best model was a tree-based method and in 
one the penalized linear regression. KNN was not picked 
as one of the best models, this simple method is known 
not to perform very well in highly dimensional spaces, and 
hence our higher number of predictors than samples may 
not be most adequate context for KNN. 

From the inspection of the results, it is clear that there is 
wide opportunity for improvement of the performance of 
this  prediction  task.  For  example,  our  feature  selection 
with MethylMix was carried out independently from the 
response;  a  future  modification  should  explore  in  more 
detail the set of 17812 genes with some variable selection 
procedure that also involves the response. Furthermore, 
we did not account for the fact that our response was a 
proportion, ranging from 0 to 1, and the addition of this 
constraint may  strengthen  our  models, for  example,  the 
linear regression  model  which  as  it  is can predict  values 
outside of the plausible range.  

Other aspect of this problem that should be addressed is 
the 
joint  prediction  of  our  7  responses,  and  not 
individually  as  we  did.  Since  the  relative  frequencies  of 
each  cell  subtype  are  related  to  each  other,  it  seems 
reasonable to predict all the frequencies together with a 
multivariate  response.  Also,  we  acknowledge  that  our 
data  set  was  rather  small,  321  samples  divided  into  the 
training  and  test  sets.  We  would  like  to  evaluate  the 
results of our work in larger data sets, from other types of 
tumor as well. 

Even though this work can be further extended with the 
suggestions  previously  mentioned,  we  were  able  to  see 
that DNA methylation provides clear signal of the immune 
composition of the tumor tissue and can be used to infer 
the relative frequencies of different types of white blood 
cells present in the samples. 

 

5 

 

3, pp. 18â€“22, 2002. 
G. Ridgeway, â€œgbm: Generalized Boosted 
Regression Models,â€ 2015. [Online]. Available: 
http://cran.r-project.org/package=gbm. 

[15] 

 
 
 
 

REFERENCES 
[1] 

E. A. Houseman, W. P. Accomando, D. C. 
Koestler, B. C. Christensen, C. J. Marsit, H. H. 
Nelson, J. K. Wiencke, and K. T. Kelsey, â€œDNA 
methylation arrays as surrogate measures of cell 
mixture distribution.,â€ BMC Bioinformatics, vol. 
13, no. 1, p. 86, 2012. 
A. E. Jaffe and R. a Irizarry, â€œAccounting for 
cellular heterogeneity is critical in epigenome-
wide association studies.,â€ Genome Biol., vol. 15, 
no. 2, p. R31, 2014. 
L. E. Reinius, N. Acevedo, M. Joerink, G. 
Pershagen, S.-E. DahlÃ©n, D. Greco, C. SÃ¶derhÃ¤ll, 
A. Scheynius, and J. Kere, â€œDifferential DNA 
methylation in purified human blood cells: 
implications for cell lineage and studies on 
disease susceptibility.,â€ PLoS One, vol. 7, no. 7, p. 
e41361, 2012. 
A. M. Newman, C. L. Liu, M. R. Green, A. J. 
Gentles, W. Feng, Y. Xu, C. D. Hoang, M. Diehn, 
and A. a Alizadeh, â€œRobust enumeration of cell 
subsets from tissue expression profiles.,â€ Nat. 
Methods, no. MAY 2014, pp. 1â€“10, 2015. 
O. G. Troyanskaya, K. Dolinski, A. B. Owen, R. B. 
Altman, and D. Botstein, â€œA Bayesian framework 
for combining heterogeneous data sources for 
gene function prediction (in Saccharomyces 
cerevisiae),â€ Proc. Natl. Acad. Sci. , vol. 100 , no. 
14 , pp. 8348â€“8353, 2003. 
W. E. Johnson, C. Li, and A. Rabinovic, â€œAdjusting 
batch effects in microarray expression data using 
empirical Bayes methods.,â€ Biostatistics, vol. 8, 
no. 1, pp. 118â€“27, 2007. 
O. Gevaert, â€œMethylMix: an R package for 
identifying DNA methylation-driven genes.,â€ 
Bioinformatics, vol. 31, no. 11, pp. 1839â€“41, 
2015. 
O. Gevaert, R. Tibshirani, and S. K. Plevritis, 
â€œPancancer analysis of DNA methylation-driven 
genes using MethylMix,â€ Genome Biol., vol. 16, 
no. 1, p. 17, 2015. 
R Core Team, â€œR: A Language and Environment 
for Statistical Computing,â€ R Found. Stat. 
Comput. Vienna, Austria., 2015. 

[2] 

[3] 

[4] 

[5] 

[6] 

[7] 

[8] 

[9] 

[10]  M. Kuhn, â€œcaret Package,â€ J. Stat. Softw., vol. 28, 

no. 5, pp. 1â€“26, 2008. 
J. Friedman, T. Hastie, and R. Tibshirani, 
â€œRegularization Paths for Generalized Linear 
Models via Coordinate Descent.,â€ J. Stat. Softw., 
vol. 33, no. 1, pp. 1â€“22, 2010. 
D. Meyer, E. Dimitriadou, K. Hornik, A. 
Weingessel, and F. Leisch, â€œMisc functions of the 
Department of Statistics (e1071), TU Wien,â€ R 
package version 1.6-2, 2014. [Online]. Available: 
http://cran.r-project.org/package=e1071. 
B. Ripley, â€œtree: Classification and Regression 
Trees. R package version 1.0-36,â€ 2015. . 
A. Liaw and M. Wiener, â€œClassification and 
Regression by randomForest,â€ R News, vol. 2, no. 

6 

[11] 

[12] 

[13] 

[14] 

 

